- Home
- PLMR vs CRSP Comparison
PLMR vs CRSP Comparison
Compare PLMR & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLMR
- CRSP
- Stock Information
- Founded
- PLMR 2013
- CRSP 2013
- Country
- PLMR United States
- CRSP Switzerland
- Employees
- PLMR N/A
- CRSP N/A
- Industry
- PLMR Property-Casualty Insurers
- CRSP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLMR Finance
- CRSP Health Care
- Exchange
- PLMR Nasdaq
- CRSP Nasdaq
- Market Cap
- PLMR 3.4B
- CRSP 3.4B
- IPO Year
- PLMR 2019
- CRSP 2016
- Fundamental
- Price
- PLMR $137.32
- CRSP $33.97
- Analyst Decision
- PLMR Buy
- CRSP Buy
- Analyst Count
- PLMR 8
- CRSP 19
- Target Price
- PLMR $127.83
- CRSP $74.35
- AVG Volume (30 Days)
- PLMR 232.0K
- CRSP 1.6M
- Earning Date
- PLMR 05-01-2025
- CRSP 05-07-2025
- Dividend Yield
- PLMR N/A
- CRSP N/A
- EPS Growth
- PLMR 43.13
- CRSP N/A
- EPS
- PLMR 4.48
- CRSP N/A
- Revenue
- PLMR $553,863,000.00
- CRSP $37,314,000.00
- Revenue This Year
- PLMR $256.77
- CRSP $49.76
- Revenue Next Year
- PLMR $20.24
- CRSP $257.28
- P/E Ratio
- PLMR $30.53
- CRSP N/A
- Revenue Growth
- PLMR 47.33
- CRSP N/A
- 52 Week Low
- PLMR $74.09
- CRSP $36.52
- 52 Week High
- PLMR $138.69
- CRSP $68.39
- Technical
- Relative Strength Index (RSI)
- PLMR 62.28
- CRSP 27.61
- Support Level
- PLMR $132.57
- CRSP $40.41
- Resistance Level
- PLMR $138.69
- CRSP $42.72
- Average True Range (ATR)
- PLMR 3.83
- CRSP 1.74
- MACD
- PLMR -0.02
- CRSP -0.83
- Stochastic Oscillator
- PLMR 73.06
- CRSP 1.14
About PLMR Palomar Holdings Inc. Common stock
Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. provide insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The companies Earthquake product generate high premium.
About CRSP CRISPR Therapeutics AG
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.